GSK plc New Liabilities Contingent Liabilities Recognised In Business Combination
GSK plc (GLAXF) reported New Liabilities Contingent Liabilities Recognised In Business Combination of GBP 280.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Notes
ifrs-full:NewLiabilitiesContingentLiabilitiesRecognisedInBusinessCombination · last filed 2026-03-06
| Period end | New Liabilities Contingent Liabilities Recognised In Business Combination 12 month |
|---|---|
| 2025-12-31 | 280.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 104.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 0.00 GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 482.00M GBP 20-F · filed 2025-03-03 |
| 2016-12-31 | 194.00M GBP 20-F · filed 2019-03-15 |